SEC Form 4 · accession 0001209191-18-006186
Foundation Medicine, Inc. · FMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vincent A. Miller
Officer — Chief Medical Officer
Period of report
Jan 29, 2018
Accepted (ET)
Jan 31, 2018 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001488613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 29, 2018 | M | 4,400 | $4.16 | A | 97,722 | D | |
| Common StockF1 | Jan 29, 2018 | S | 4,400 | $75.00 | D | 93,322 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $4.16 | Jan 29, 2018 | M | 4,400 | D | — | Mar 7, 2023 | Common Stock | 4,400 | 2,633 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2017.
- F2The option was granted on March 7, 2013 and vested in equal quarterly installments beginning on June 7, 2013 until fully vested on March 7, 2017.